Coloplast A/S (CPSE:COLO B) entered into a definitive agreement to acquire SAS LILIAL from Naxicap Partners, Ouest Croissance SCR, founder and management for €35.5 million on December 18, 2017. The transaction will take place on a cash and debt free basis. The deal is subject to customary closing conditions. The transaction is expected to close before the year-end 2017. Stéphane Huten, Arnaud Deparday, Bob Zeller, Bruno Knadjian and Laurent Ragot of Hogan Lovells acted as legal advisor to Naxicap Partners, Ouest Croissance SCR and management. Dimitri Dimitrov, David-James Sebag, Pierre-Antoine Degrolard and Rémi Avon of Gide Loyrette Nouel acted as legal advisor to Coloplast. Philippe Guézenec, Thomas Hamelin and Sophie Lerond of Clearwater International France acted as financial advisor to Naxicap Partners, Ouest Croissance, the founder and the management. Coloplast A/S (CPSE:COLO B) completed the acquisition of SAS LILIAL from Naxicap Partners, Ouest Croissance SCR, founder and management on January 10, 2018.